CSIMarket


Cryo cell International Inc   (CCEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Cryo cell International Inc

CCEL's Fundamental analysis








Looking into Cryo Cell International Inc growth rates, revenue grew by 2.46 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 48

Healthcare Facilities industry recorded growth of revenues by 8.64 %

Cryo Cell International Inc 's net income grew by 45.79 % in III. Quarter 2023 year on year, above company average,

More on CCEL's Growth


Cryo Cell International Inc
current PE on trailing twelve month basis is below Healthcare Facilities industry average.

Cryo Cell International Inc PEG ratio is at 0.33 Cryo Cell International Inc realized cash outflow of $ -0.28per share in trailing twelve-month period.
Company
30.29
PE TTM   
Industry
535.94
PE TTM    
Company's Price to Sales ratio is at 2.41.
Healthcare Facilities industry's Price to Sales ratio is at 1.15.


More on CCEL's Valuation
 
 Total Debt (Millions $) 10
 Dividend TTM ($) 0.91 $
 Dividend Yield TTM (%) 10.07 %
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.86
 Tangible Book Value (Per Share $) -0.40

Cryo Cell International Inc
current PE on trailing twelve month basis is below Healthcare Facilities industry average.

Cryo Cell International Inc PEG ratio is at 0.33 Cryo Cell International Inc realized cash outflow of $ -0.28per share in trailing twelve-month period.
Company
30.29
PE TTM   
Industry
535.94
PE TTM    
Company's Price to Sales ratio is at 2.41.
Healthcare Facilities industry's Price to Sales ratio is at 1.15.


More on CCEL's Valuation

  Market Capitalization (Millions $) 75
  Shares Outstanding (Millions) 8
  Employees -
  Revenues (TTM) (Millions $) 31
  Net Income (TTM) (Millions $) 3
  Cash Flow (TTM) (Millions $) -2
  Capital Exp. (TTM) (Millions $) -5
  Total Debt (Millions $) 10
  Dividend TTM ($) 0.91 $
  Dividend Yield TTM (%) 10.07 %
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.86
  Tangible Book Value (Per Share $) -0.40

  Market Capitalization (Millions $) 75
  Shares Outstanding (Millions) 8
  Employees -
  Revenues (TTM) (Millions $) 31
  Net Income (TTM) (Millions $) 3
  Cash Flow (TTM) (Millions $) -2
  Capital Exp. (TTM) (Millions $) -5


    CCEL's Profitability Comparisons
Cryo Cell International Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2023 to 14.75 % from 13.22 % in II. Quarter.

Cryo Cell International Inc net profit margin of 8.65 % is currently ranking no. 6 in Healthcare Facilities industry, ranking no. 113 in Healthcare sector and number 1480 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 0.54
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.47
  Inventory Turnover Ratio (TTM) 9.21



Cryo Cell International Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2023 to 14.75 % from 13.22 % in II. Quarter.

Cryo Cell International Inc net profit margin of 8.65 % is currently ranking no. 6 in Healthcare Facilities industry, ranking no. 113 in Healthcare sector and number 1480 in S&P 500.

More on CCEL's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com